ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,576.98
0.07%
US Tech 100
19,930.80
0.19%
Dow Jones
39,291.97
-0.13%
Brent Oil
84.365
-0.39%
Bitcoin
57,719.17
-0.52%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Zai Lab Ltd (ZLAB) Quote

Zai Lab Ltd

Zai Lab Ltd (ZLAB)

NASDAQ
16.62
-0.35
(-2.06%)
Closed July 09 4:00PM
Delayed by 15 minutes
16.97
0.35
(2.11%)
After Hours: 6:41PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
16.97
Bid
16.27
Ask
17.63
Volume
541,979
16.20 Day's Range 16.82
0.00 52 Week Range 0.00
Market Cap
1.684B
Previous Close
16.97
Open
16.51
Last Trade
100
@
16.97
(formt)
Last Trade Time
Financial Volume
$ 8,981,577
VWAP
16.5718
Average Volume (3m)
-
Shares Outstanding
99,208,743
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Zai Lab Ltd

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of th... Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.zailaboratory.com
Headquarters
George Town, Cym
Founded
1970
Zai Lab Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZLAB. The last closing price for Zai Lab was $16.97. Over the last year, Zai Lab shares have traded in a share price range of $ 0.00 to $ 0.00.

Zai Lab currently has 99,208,743 shares outstanding. The market capitalization of Zai Lab is $1.68 billion.

ZLAB Latest News

More News

Form 8-K - Current report

6 hours ago
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

June 18 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 18 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 11 2024
Edgar (US Regulatory)

Zai Lab Announces Dr. Harald Reinhart to Retire as Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases; Dr. Rafael Amado to be Appointed President, Head of Global R&D

  Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced today that following a distinguished career, Harald Reinhart, M.D., President, Head of Global Development, Neuroscience, Autoimmune and...

June 11 2024
Business Wire

Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis

This is the first compound in Zai’s portfolio of internally developed drugs to advance into Phase 2, demonstrating Zai’s global capabilities Based on a proof-of-concept study, ZL-1102 is the...

May 22 2024
Business Wire

Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China

Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization China NMPA approval based on...

May 20 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

May 16 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SNGXSoligenix Inc
$ 7.42
(271.00%)
134.15M
ZAPPZapp Electric Vehicles Group Ltd
$ 17.9001
(93.72%)
45.5M
PEGYPineapple Energy Inc
$ 2.30
(91.67%)
77.57M
ATNF180 Life Sciences Corporation
$ 2.9017
(79.12%)
31.21M
QUREuniQure NV
$ 6.65
(75.93%)
51.49M
NVOSNovo Integrated Sciences Inc
$ 0.4874
(-35.44%)
3.12M
FAASDigiAsia Corporation
$ 3.65
(-34.17%)
49.17k
INDVIndivior PLC
$ 10.18
(-33.64%)
2.95M
CLEUChina Liberal Education Holdings Ltd
$ 0.3905
(-31.59%)
9.24M
HUBCWHub Cyber Security Ltd
$ 0.0165
(-31.25%)
1.9k
NVDANVIDIA Corporation
$ 131.38
(2.48%)
287.03M
MAXNMaxeon Solar Technologies Ltd
$ 0.2451
(-9.22%)
233.65M
TSLATesla Inc
$ 262.33
(3.71%)
160.74M
SNGXSoligenix Inc
$ 7.42
(271.00%)
134.15M
INTCIntel Corporation
$ 34.59
(1.77%)
97.8M

Discussion

View Full Feed
Dr Blunt Dr Blunt 3 minutes ago
0.000001 0.00 (0.00%) Volume: - 0
$MSTO
Masterbeat Corporation
MSTO
TechandBio TechandBio 3 minutes ago
Growing number of
global distribution
agreements. More to come!



Insurance Reimbursement:
CPT III for
breast cancer
cryoablation facility
fee established.

51 IP Patents

Excellent patient & physicia
ICCM
rocketeer357 rocketeer357 3 minutes ago
The warts are starting to pop out in Milwaukee's pitching as well. Looks like some smoke and mirrors in the first half. Somehow I think management in Milwaukee was stunned by how well the team has performed in the first half, and now they're trying to pretend they care. Item #1: Dallas Keuchel signe
Lurker3 Lurker3 4 minutes ago
apparently I'm not smarter than some.

But you are stupider than many
LWLG
Carjockey2 Carjockey2 4 minutes ago
https://x.com/BidSlapper/status/1810830002717389200?t=1456FDkf7PcyH3htYVxzdg&s=19
FSRNQ
rooster rooster 4 minutes ago
Russia collusion hoax the both sides have fine people hoax the Russia laptop hoax
delerious1 delerious1 5 minutes ago
the worst things about OTC chartists is that they are always trying to hype the value of charting and the fact that they are doing it on a micropenny stock that does not follow any trend at all, other than reacting to news, volume or other daily factors....so they, the chartists are essentially lyin
RONN
cjstocksup cjstocksup 5 minutes ago
I have done that hundreds of times with an answer back in a millisecond. You cannot even say 1 one thousand before you have a reply back in your email box saying you are permanently suspended and no way to get back on. I cannot even send myself an email that fast. I am sure they have it set up so no
thetinman thetinman 5 minutes ago
Oops, My bad, it's ONLY BEEN 119 days since I left a voicemail as a P-CRAP shareholder at +16174811971 with NO CALL BACK !! that's ridiculous for such a AMAZING CEO at least in his mind..

As Joe Biden would say, "Come on man "

Josh,
You're an ALLEGED B*&#x
PTOP
bull runs bull runs 5 minutes ago
Conversely, you don’t want it when it is HAPPENING and I guarantee you that’s how the MAJORITY of Americans are going to see it! Lmfao. Democrats gave been schooled. 😂😂😂. There’s no hiding it now. Democrats want Illegals to vote in elections. Congratulations on helping us
DJT
rooster rooster 5 minutes ago
Yes and failed but that was not one of the two
stocksbelow1 stocksbelow1 6 minutes ago
Nope. You spew hatred without DD. I try and provide DD. I will wish you the best however!!!
GTVH
JusDePomme JusDePomme 6 minutes ago
Hi biochem..I see u as a friend. Don't buy more the other stock! Chance u make money slim. There are many stock u can make money than that one uncertainty future listing
EMGE
gfp927z gfp927z 6 minutes ago
Xena, With AVXL, I'll need to get up to speed more on their clinical programs. One thing with bio stocks is they take a ton of research, and you still can't really get the full picture. The science is so advanced and specialized, and competitive landscape so complex, I decided to mainly follow
AVXL
boston127 boston127 6 minutes ago
How many stocks do you own?

Every time I go to a board where a stock has skyrocketed, you are there.
LGVN
TheShadow TheShadow 7 minutes ago
Cardano Ranks 26 on Top Brand Intimacy Rankings.
https://mblm.com/lab/brandintimacy-study/rankings/
ADAUSD
Giovanni Giovanni 7 minutes ago
I have a pack of Red Sun up for bids!
Bidding starts at 25 shares.
Good Luck To All;0)))
XXII
chklingon chklingon 7 minutes ago
Because?
TSLA
SSKILLZ1 SSKILLZ1 8 minutes ago
another 2 run homer. worst bulpen i have ever seen.
fuagf fuagf 9 minutes ago
Sure seems he is that. LOL I guess we'll always be visited by them. Just think
of the outlet we provide. Pressure cookered people welcome, for a time.
space~farm space~farm 9 minutes ago
I don’t think you understand oncology or ORR.

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/orr
NWBO
SeekTruthAlways SeekTruthAlways 9 minutes ago
Lighter, have you made the appointment for you and drunkard Claycamp to address your drug and alcohol issues:

https://whitesandstreatment.com/locations/florida/sarasota/
ASRE
SloGin SloGin 9 minutes ago
Looks like 1 billion shares returned to treasury!

https://www.otcmarkets.com/otcapi/company/financial-report/402581/content



HIRU
drugmanrx drugmanrx 9 minutes ago
https://x.com/SunPacificPower/status/1810783818426765624
SNPW
Denisk Denisk 9 minutes ago
In the 13 D filing by Sarissa on Jan 13 , 2022 for the 24 million shares purchase see the summary below:
Now actually it was $4.45 per share average based on the last paragraph., 24 million shares for a total of $106,921,000.

1/24/22, 2:30 PM https://www.sec.gov/Archives/edgar/
AMRN

Your Recent History

NASDAQ
ZLAB
Zai Lab
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved